Skip to main content

Archive

Trial for blood tests to diagnose dementia accepts first participants at Warneford Hospital

A country-wide trial aiming to revolutionise how dementia is diagnosed using blood tests is now underway, in a bid to improve the UK’s diagnosis rate.


New study for Treatment-Resistant Depression launches at Oxford Health Clinical Research Facility

Recently, the NIHR Oxford Health Clinical Research Facility (OH CRF) has begun researching a new potential drug treatment for Treatment-Resistant Depression.


Oxford Health Biomedical Research Centre January Newsletter now available

The January issue of the OH BRC Newsletter is available to read on the OH BRC website.


Oxford clinical lecturer awarded the Sir Jules Thorn Award for internationally outstanding research

Dr Maxime Taquet has been awarded the 2024 Sir Jules Thorn Award for Biomedical Research. The Award recognises the outstanding quality of his cutting-edge research.


Oxford Health NHS Foundation Trust Research & Development 2024 Highlights

As the new year begins, we take the opportunity to reflect on the many successes, changes and developments during 2024 across the research infrastructures at Oxford Health NHS Foundation Trust (OHFT).


Oxford Health Director of Research and Development discusses READ-OUT with BBC South

Oxford Health NHS Foundation Trust Director of Research and Development, Professor Vanessa Raymont featured on the BBC.


Oxford and Southampton study identifies the most effective treatments for ADHD in adults

Oxford and Southampton researchers have found that atomoxetine and a class of drug known as stimulants are the most effective treatments in the management of attention deficit hyperactivity disorder (ADHD) symptoms in adults.


Oxford Health Biomedical Research Centre (OH BRC) December Newsletter now available

The December issue of the OH BRC Newsletter is available to read on the OH BRC website.


Do you or a loved one have Down syndrome? The ABATE study Part 2 is recruiting now!

The ABATE study Part 2 is testing an investigational vaccine to slow the progression of Alzheimer’s disease in people with Down Syndrome, as currently there is no cure for Alzheimer’s disease.


First ever Mohammed bin Rashid Al Maktoum Knowledge Award win for mental health

The Knowledge Award recognises exceptional achievements which have contributed to the advancement of science and positively impacted societies and humanity.